Procedure: MA Renewal
Country: Global Procedure
Version #: 01/17/2024
Author: Daria Kostiuchenko
Editor: Daria Kostiuchenko
ID: GP-MD-PhR-SR
Category: Pharmaceuticals/MD&IVD
Validity: Lifetime in most countries
Certified by: Vlad Reznikov
Copyright: Pattern of USA Inc.
SUMMARY
The Market Authorization (MA) is typically valid for a period of 5 years in many countries. However, to extend the validity beyond this initial period, an Application for renewal must be submitted at least 9 months prior to the expiration date.
Once renewed, licenses and registrations are not subject to a specific time limit. However, in certain cases, the National Regulatory Authority (NRA/NCA) may order an additional renewal of 5 years to ensure the continued safe marketing of the medicinal product. This additional renewal is implemented to provide further assurance of the post-marketing product’s safety and compliance with regulations.
A smaller set of documents is needed compared to the new MA for renewal. The dossier focuses on safety-related documentation and post-marketing studies. It is important to submit properly legalized administrative documents and specific national forms. Renewal also involves expert evaluation of updated data on the benefit-risk ratio.

Must-Have Requirements, Recognized Standards, and Certification:
- Updated registration file
- Post-marketing surveillance report
Nice-to-have:
- Regulatory Intelligence and Strategic Consulting
see GP-PhR-RI-SR card
- PSUR/PSMR
Typical Gaps and Deficiencies: Incomplete post-marketing surveillance, outdated standards, untimely submission, missing or incorrect document confirming the variations or changes
Implementation Period: After NRA approval
Deliverables: MA Renewal
PHASE | TASK | TASK | START | DURATION | Fee | KPI | ||
NUMBER | TITLE | OWNER | W/M/Q/Y | in weeks | 3rd Party | Service | State | |
0 | In-house Pre-Submission Activity | |||||||
0.1 | NDA signing or validation | Executor | week 1 | 1 | ||||
0.2 | Contract Closing | MAH | week 1 | 1 | ||||
0.3 | SOW is approved by MAH | MAH | week 1 | 1 | SOW | |||
0.4 | POA issuance and shipping | MAH | week 2 | 1 | ||||
0.5 | Invoice is sent to MAH and paid | Executor | week 3 | 1 | POP | |||
I | Review | |||||||
I.1 | Filling of the Application form and renewal dossier | Executor | week 4 | 1 | ||||
I.2 | Submission and assessment of the Application form | Executor | week 5 | 1 | ||||
I.3 | Answers on the deficiencies if any | MAH | week 6 | 2 | ||||
I.4 | NRA payment | MAH | week 8 | 1 | Report | |||
I.5 | Update dossier Submission | Executor | week 9 | 1 | ||||
II | Studies | |||||||
II.1 | Initial expert assessment of the dossier | NRA | week 10 | 4 | Reports | |||
III | Q&A | |||||||
III.1 | Analysis and addressing Qs to MAH | Executor | week 14 | 1 | ||||
III.2 | Answering with relevant documents | MAH | week 15 | 1 | ||||
III.3 | Official Response Evaluation | NRA | week 19 | 4 | ||||
III.4 | Approval (GoTo Ph.IV) or Query (Rpt. Ph.III) | NRA | week 20 | 1 | Approval or Q&A | |||
IV | Approval | |||||||
IV.1 | NRA Letter | NRA | week 21 | 1 | Approval | |||
IV.2 | NRA Conclusion publication | NRA | week 22 | 1 | Publication | |||
IV.3 | NRA Listing | Executor | week 23 | 1 | Listing | |||
IV.4 | Reporting to MAH | Executor | week 24 | 1 | Report | |||
F | Final Phase In-house Post-Authorization Activity | |||||||
F.1 | Service Acceptance Certificate signing | MAH | week 25 | 1 | ||||
F.2 | Final Invoice | Executor | week 25 | 1 | ||||
F.3 | Final Payment | MAH | week 25 | 1 | ||||
F.4 | Contract Termination | Executor | week 26 | 1 | ||||
F.5 | Archiving and limiting access | Executor | week 27 | 1 | Archiving |
Feel free to submit a Request for Proposal (RFP) for a specific country or territory to info@patternofusa.com